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Conclusion: Serum phospholipid status is modulated in patients with
CAD. This involves a significant modulation of the PC distribution between
lipoprotein subclasses and probably reflects an abnormality in the phospho-
lipid transfer activity (PLTP activity) representing a useful marker of cardio-
vascular risk.
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Introduction: Coronary artery disease (CAD) is a multifactorial disease,
its expression probably being influenced by the interaction of genetic and
environmental risk factors. Genetic variation in the estrogen receptor-alpha
gene (ERS1) has been associated with CAD in several populations worldwide,
but results are still controversial. In the present study, we examined the asso-
ciation between the c.454-397T>C: PvuII restriction site (rs2234693) and
c.454-351A>G:XbaI restriction site (rs9340799) polymorphisms (SNPs) and
myocardial infarction (MI) in a sample of the Tunisian population.
Material and methods: The case group included 294 patients with MI,
and the control group comprised 275 individuals with angiographically normal
coronary arteries and without signs or symptoms of MI. ESR1 PvuII and XbaI
polymorphism was determined by polymerase chain reaction (PCR)-restriction
fragment length polymorphism (RFLP) method.
Results: Genotype distributions of the SNPs in the control and patient
groups were consistent with those expected for samples in Hardy-Weinberg
equilibrium (p> 0.05). The Genotype distribution and the relative allelic fre-
quencies of the –397T>C and – 351A>G polymorphisms were not signifi-
cantly different between the control and patient groups (p=NS). Moreover, the
odds ratio for MI associated with the c.454-397C (OR=1.02, 95% CI 0.81-
1.30), and c.454-351G (OR=1.24, 95% CI 0.98-1.58) variants failed to reach
statistical significance.
Conclusion: In the current study, we were unable to demonstrate a signif-
icant association of the ESR1 c.454-397T>C and c.454-351A>G polymor-
phisms with MI. These results do not support the extent of risk associated with
developing MI previously reported for the ESR1 c.454-397T>C and c.454-
351A>G polymorphisms.
